Identifying the Target of an Antiparasitic Compound in Toxoplasma Using Thermal Proteome Profiling

Abstract

Apicomplexan parasites include the causative agents of malaria and toxoplasmosis. Cell-based screens in Toxoplasma previously identified a chemical modulator of calcium signaling (ENH1) that blocked parasite egress from host cells and exhibited potent antiparasitic activity. To identify the targets of ENH1, we adapted thermal proteome profiling to Toxoplasma, which revealed calcium-dependent protein kinase 1 (CDPK1) as a target. We confirmed the inhibition of CDPK1 by ENH1 in vitro and in parasites by comparing alleles sensitive or resistant to ENH1. CDPK1 inhibition explained the block in egress; however, the effects of ENH1 on calcium homeostasis and parasite viability were CDPK1-independent, implicating additional targets. Thermal proteome profiling of lysates from parasites expressing the resistant allele of CDPK1 identified additional candidates associated with the mitochondria and the parasite pelliclecompartments that potentially function in calcium release and homeostasis. Our findings illustrate the promise of thermal profiling to identify druggable targets that modulate calcium signaling in apicomplexan parasites.

Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development

“…In recent years, MS-CETSA has garnered attention as a powerful tool to study drug target engagement. The CETSA methodology and its variants were originally developed to assist in anticancer drug target discovery efforts 39,63 ; however, the use of this methodology has now been expanded to study drug target engagement in human pathogens, such as E. coli 64 , toxoplasma 65 , and P. falciparum 32,33,66,67 . In our previous work, we demonstrated the value of CETSA for antimalarial drug deconvolution by identifying PfPNP as a direct molecular target of QN but also MFQ 33 .…”

Genetic screens reveal a central role for heme metabolism in artemisinin susceptibility

“…We attempted to use immunoprecipitations with either wild type or catalytically dead DegP2 to define DegP2's binding partners, but we were unable to reliably detect interactions. Instead, we turned to thermal proteome profiling (TPP) to identify proteins that change in thermal stability when DegP2 is knocked down [64][65][66][67] , implying a direct or indirect interaction with DegP2. We collected DegP2 cKD parasites that had been treated with rapamycin or a vehicle control, then heated them to temperatures between 37°C and 67°C.…”

Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183

“…To provide conclusive evidence that PanAms directly bind to ACS, thereby inhibiting ACS activity, we used the recently developed cellular thermal shift assay (CETSA) (25,26) inhibited ACS activity with an IC50 of 154 nM, whereas 4'P-MMV693183 only showed weak activity (Fig 3b)…”